Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Lidocaine for Chronic Pain After Mastectomy
NCT06910644Recruiting
- Sponsor
- Cairo University
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine and Lidocaine Hydrochloride Injection, without epinephrine in chronic pain (3 arms), sponsored by Cairo University. Primary endpoint: Incidence of the chronic pain. Started Apr 2025; status: recruiting.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT06910644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06910644.